Simulations Plus Partners With Nvidia For Drug Modeling | dailyai.report
23 stories from today
Industry
114d ago
Simulations Plus Partners With Nvidia For Drug Modeling
Simulations Plus partnered with Nvidia to integrate GPU-powered computing into pharmaceutical simulation software. The collaboration targets quantitative systems pharmacology and pharmacokinetics workflows to increase processing speed and scale. This is an incremental step in digitizing drug development.
The Signal
Researchers can now run complex biological models with significantly lower latency.